10x Genomics (TXG) has issued an announcement.
Alan V. Mateo has been appointed to the Board of Directors of 10x Genomics, Inc. as a Class II director, with his term set to last until the 2027 annual meeting of stockholders. Mateo, an experienced executive with a strong background in sales and operations, previously served at Veeva Systems Inc. and has held various senior roles at Medidata Solutions, Inc. and PeopleSoft. His expertise is expected to be an asset to the company, bolstered by his academic qualifications in Computer Science and Marketing.
See more data about TXG stock on TipRanks’ Stock Analysis page.
